CompareMarketResearchRequest a sample
Home / Healthcare / Tissue Engineering

Healthcare · Market report

Tissue Engineering Market Size, Share and Forecast 2026-2036

The global tissue engineering market is worth USD 6.0 bn in 2026 and is forecast to reach USD 16.4 bn by 2036, growing at a 10.5% CAGR. United States is the largest country market and Scaffolds and biomaterial matrices is the largest by product segment.

USD 6.0 bnMarket size 2026
USD 16.4 bnForecast 2036
10.5%CAGR 2026-2036
United StatesLargest country

Request a free sample Jump to the forecast

Report price: Starts from USD 1,999

5 segmentation views25 countries2026 to 2036 yearly forecast

Market overview

The global tissue engineering market is worth USD 6.0 bn in 2026 and is forecast to reach USD 16.4 bn by 2036, growing at a 10.5% CAGR. United States is the largest country market and Scaffolds and biomaterial matrices is the largest by product segment.

ScopeEngineered tissues and supporting products for repair or replacement of skin, cartilage, bone, vascular and other tissue, including cell-based grafts, scaffolds and biomaterial matrices.
IndustryHealthcare
Value 2025USD 5.5 bn
Value 2026USD 6.0 bn
Value 2036USD 16.4 bn
CAGR 2026-203610.5%
Volume 20262,401 thousand procedures
Volume 20366,017 thousand procedures
Average price 2026USD 2,520 per procedure
Report priceStarts from USD 1,999
PublishedNovember 2026

Request a free sample of this report

Tissue Engineering market size and forecast, 2026-2036

Exhibit 1The global tissue engineering market is forecast to grow from USD 6.0 bn in 2026 to USD 16.4 bn by 2036, more than doublingGlobal market value in USD: 2025 base year, 2026 estimate and forecast to 2036. CAGR 2026 to 2036: 10.5%
Tissue Engineering market value, 2025 to 2036Market value by year. 2025: USD 5.5 bn; 2026: USD 6.0 bn; 2027: USD 6.7 bn; 2028: USD 7.4 bn; 2029: USD 8.2 bn; 2030: USD 9.0 bn; 2031: USD 10.0 bn; 2032: USD 11.0 bn; 2033: USD 12.2 bn; 2034: USD 13.4 bn; 2035: USD 14.9 bn; 2036: USD 16.4 bn. Compound annual growth rate 2026 to 2036: 10.5%.20256.0 bn202610.0 bn203116.4 bn203610.5% CAGR

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

YearMarket value
2026USD 6.0 bn
2027USD 6.7 bn
2028USD 7.4 bn
2029USD 8.2 bn
2030USD 9.0 bn
2031USD 10.0 bn
2032USD 11.0 bn
2033USD 12.2 bn
2034USD 13.4 bn
2035USD 14.9 bn
2036USD 16.4 bn

Tissue Engineering market segmentation

By product

Exhibit 2Scaffolds and biomaterial matrices is the largest segment by product, with 42.0% of 2026 revenueEstimated share of 2026 global revenue, by product
Tissue Engineering market share by product, 2026Share of 2026 revenue by product. Scaffolds and biomaterial matrices: 42.0%; Cell-based grafts: 26.0%; Acellular tissue products: 22.0%; Bioprinted and other products: 10.0%.Scaffolds and biomaterial matrices42.0%Cell-based grafts26.0%Acellular tissue products22.0%Bioprinted and other products10.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Scaffolds and biomaterial matrices42.0%37.0%USD 2.5 bn9.1%
Cell-based grafts26.0%28.7%USD 1.6 bn11.6%
Acellular tissue products22.0%18.5%USD 1.3 bn8.6%
Bioprinted and other products10.0%15.7%USD 605 mn15.6%

By application

Exhibit 3Skin and wound repair adds the most revenue by application, growing from USD 2.2 bn in 2026 to USD 6.0 bn by 2036Estimated revenue in USD by application, 2026 and 2036 forecast
Tissue Engineering market by application, 2026 and 2036Revenue by application in 2026 and 2036. Skin and wound repair: USD 2.2 bn in 2026, USD 6.0 bn in 2036, change +176%; Orthopaedics and musculoskeletal: USD 1.8 bn in 2026, USD 4.6 bn in 2036, change +152%; Other: USD 786 mn in 2026, USD 2.3 bn in 2036, change +189%; Cardiovascular: USD 726 mn in 2026, USD 2.2 bn in 2036, change +202%; Dental and oral: USD 544 mn in 2026, USD 1.4 bn in 2036, change +152%.20262036 forecastChangeSkin and wound repair+176%2.2 bn6.0 bnOrthopaedics and musculoskeletal+152%1.8 bn4.6 bnOther+189%786 mn2.3 bnCardiovascular+202%726 mn2.2 bnDental and oral+152%544 mn1.4 bn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Skin and wound repair36.0%36.6%USD 2.2 bn10.7%
Orthopaedics and musculoskeletal30.0%27.9%USD 1.8 bn9.7%
Cardiovascular12.0%13.4%USD 726 mn11.7%
Dental and oral9.0%8.4%USD 544 mn9.7%
Other13.0%13.8%USD 786 mn11.2%

By material

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Collagen28.0%24.0%USD 1.7 bn8.8%
Synthetic polymers26.0%26.0%USD 1.6 bn10.5%
Ceramics and bone graft20.0%20.0%USD 1.2 bn10.5%
Decellularised matrix26.0%30.0%USD 1.6 bn12.1%

By cell source

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Autologous40.0%38.0%USD 2.4 bn9.9%
Allogeneic34.0%34.0%USD 2.1 bn10.5%
Stem cell derived26.0%28.0%USD 1.6 bn11.3%

By end user

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Hospitals48.0%44.0%USD 2.9 bn9.5%
Cosmetic and aesthetic clinics20.0%22.0%USD 1.2 bn11.6%
Biotech and research32.0%34.0%USD 1.9 bn11.2%

Top 25 countries for tissue engineering by revenue

Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 85.5% of 2026 revenue and the 25 countries below together hold 95.6%.

Exhibit 4United States is the largest country market at USD 2.5 bn in 2026, and the three largest countries hold 58.0% of global revenueEstimated 2026 revenue in USD and share of the global market, ten largest countries
Tissue Engineering market, ten largest countries in 2026Ten largest countries by 2026 revenue. United States: USD 2.5 bn, 42.0%; China: USD 544 mn, 9.0%; Germany: USD 424 mn, 7.0%; Japan: USD 424 mn, 7.0%; United Kingdom: USD 272 mn, 4.5%; France: USD 242 mn, 4.0%; South Korea: USD 212 mn, 3.5%; Italy: USD 182 mn, 3.0%; Canada: USD 182 mn, 3.0%; Australia: USD 151 mn, 2.5%.United States2.5 bn 42.0%China544 mn 9.0%Germany424 mn 7.0%Japan424 mn 7.0%United Kingdom272 mn 4.5%France242 mn 4.0%South Korea212 mn 3.5%Italy182 mn 3.0%Canada182 mn 3.0%Australia151 mn 2.5%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

#CountryValue 2026Share 2026Value 2036CAGR 2026-36
1United StatesUSD 2.5 bn42.0%USD 6.4 bn9.7%
2ChinaUSD 544 mn9.0%USD 2.1 bn14.2%
3GermanyUSD 424 mn7.0%USD 1.1 bn9.7%
4JapanUSD 424 mn7.0%USD 1.2 bn10.7%
5United KingdomUSD 272 mn4.5%USD 690 mn9.7%
6FranceUSD 242 mn4.0%USD 608 mn9.6%
7South KoreaUSD 212 mn3.5%USD 706 mn12.8%
8ItalyUSD 182 mn3.0%USD 460 mn9.7%
9CanadaUSD 182 mn3.0%USD 460 mn9.7%
10AustraliaUSD 151 mn2.5%USD 394 mn10.1%
11SpainUSD 137 mn2.3%USD 338 mn9.5%
12NetherlandsUSD 81 mn1.3%USD 200 mn9.5%
13SwitzerlandUSD 60 mn1.0%USD 148 mn9.4%
14IndiaUSD 48 mn0.8%USD 169 mn13.3%
15BrazilUSD 41 mn0.7%USD 143 mn13.3%
16IsraelUSD 36 mn0.6%USD 125 mn13.3%
17SwedenUSD 31 mn0.5%USD 79 mn9.6%
18BelgiumUSD 28 mn0.5%USD 71 mn9.5%
19TaiwanUSD 26 mn0.4%USD 66 mn9.7%
20SingaporeUSD 24 mn0.4%USD 85 mn13.4%
21TurkeyUSD 22 mn0.4%USD 79 mn13.4%
22MexicoUSD 21 mn0.3%USD 74 mn13.3%
23AustriaUSD 20 mn0.3%USD 49 mn9.4%
24DenmarkUSD 19 mn0.3%USD 46 mn9.4%
25PolandUSD 18 mn0.3%USD 62 mn13.1%
Rest of worldUSD 264 mn4.4%USD 680 mn9.9%
Exhibit 5United States and China account for 52% of the USD 10.4 bn the market is forecast to add by 2036Forecast revenue added between 2026 and 2036 by country, in USD
Tissue Engineering market, where the growth to 2036 comes fromRevenue added between 2026 and 2036. Market value 2026: USD 6.0 bn. United States: +USD 3.9 bn; China: +USD 1.5 bn; Japan: +USD 742 mn; Germany: +USD 644 mn; South Korea: +USD 494 mn; 20 other countries: +USD 2.7 bn; Rest of world: +USD 416 mn. Market value 2036: USD 16.4 bn.Market value 20266.0 bnUnited States+3.9 bnChina+1.5 bnJapan+742 mnGermany+644 mnSouth Korea+494 mn20 other countries+2.7 bnRest of world+416 mnMarket value 203616.4 bn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

Competitive landscape

Group 1: Global leaders

  • Integra LifeSciences
  • Smith+Nephew
  • AbbVie
  • Organogenesis
  • Medtronic
  • Geistlich

Group 2: Regional and specialist players

  • Vericel
  • MiMedx Group
  • Axogen
  • Collagen Solutions
  • LifeNet Health
  • Cook Biotech
  • Aroa Biosurgery
  • Tissue Regenix

Group 3: Emerging and niche players

  • Humacyte
  • CollPlant
  • BICO
  • Organovo
  • Mesoblast
  • Orthocell
  • Elutia

Research methodology

Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the tissue engineering market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.

The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 10.5% is calculated from the resulting values.

The market is divided by product, by application, by material, by cell source, by end user. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.

Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.

Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.

Read the full research methodology

Frequently asked questions

How big is the tissue engineering market?

The global tissue engineering market is estimated at USD 5.5 bn in 2025 and USD 6.0 bn in 2026.

How fast will the tissue engineering market grow?

It is forecast to reach USD 16.4 bn by 2036, a compound annual growth rate of 10.5% from 2026, an increase of USD 10.4 bn.

Which country is the largest market for tissue engineering?

United States is the largest market by revenue at USD 2.5 bn in 2026, 42.0% of the global total. The three largest countries together hold 58.0%.

Which country is growing fastest?

Among the ten largest markets, China is growing fastest at 14.2% a year from 2026 to 2036.

Which tissue engineering segment is largest?

In the by product split, Scaffolds and biomaterial matrices is the largest segment with 42.0% of 2026 revenue.

Who are the leading tissue engineering companies?

Global leaders include Integra LifeSciences, Smith+Nephew, AbbVie, Organogenesis.

Need the full report?

Request a sample to see the structure, tables and country detail.

Request a free sample

Related markets in Healthcare

← Theranostic Workflow Platforms Touch Activated Phlebotomy Devices →

All Healthcare markets →

Request a sample